Kazia Therapeutics Limited (NASDAQ:KZIA) Short Interest Up 10.0% in March

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 141,400 shares, an increase of 10.0% from the March 15th total of 128,600 shares. Based on an average daily trading volume, of 53,000 shares, […]

Related Keywords

Australia ,Sydney ,New South Wales ,Graham Edmund Kelly ,Kazia Therapeutics Limited ,Kazia Therapeutics Ltd ,Mission Capital ,Nasdaq ,Get Rating ,Kazia Therapeutics ,Kazia Therapeutics Daily ,Nasdaq Kzia ,Kzia ,Medical ,Stocks ,Options ,Put ,Call ,